| __timestamp | Alpine Immune Sciences, Inc. | Amicus Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 47624000 |
| Thursday, January 1, 2015 | 16054000 | 76943000 |
| Friday, January 1, 2016 | 23316000 | 104793000 |
| Sunday, January 1, 2017 | 10626000 | 149310000 |
| Monday, January 1, 2018 | 28970000 | 270902000 |
| Tuesday, January 1, 2019 | 35847000 | 286378000 |
| Wednesday, January 1, 2020 | 27185000 | 308443000 |
| Friday, January 1, 2021 | 58742000 | 272049000 |
| Saturday, January 1, 2022 | 70243000 | 276677000 |
| Sunday, January 1, 2023 | 80904000 | 152381000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Amicus Therapeutics consistently outpaced Alpine Immune Sciences, with R&D expenses peaking at nearly 308% higher in 2020. However, Alpine Immune Sciences has shown remarkable growth, increasing its R&D spending by over 560% from 2014 to 2023. This surge reflects a strategic pivot towards aggressive innovation, particularly evident in the last three years.
As the biotech industry continues to expand, these spending patterns highlight the dynamic strategies companies employ to stay competitive and drive breakthroughs in medical science.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Research and Development Investment: Genmab A/S vs Alpine Immune Sciences, Inc.
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.